PDCD1 and neoplasm: To evaluate whether Aza treatment of KPT277 cells is able to stimulate splenocyte anti-tumor cytotoxicity and whether PD-1/PD-L1 expression might interfere, DMSO or Aza-treated KPT277 cells were co-incubated with splenocytes from mice implanted with KPT277 tumors.